openPR Logo
Press release

BCG Vaccine Market - Rise in R&D Activities Related To Vaccines, And Growth in Government Initiatives Boost the Market Growth

04-08-2019 09:01 AM CET | Health & Medicine

Press release from: Allied Market Research

BCG Vaccine Market

BCG Vaccine Market

The BCG Vaccine Market is estimated at $ 20,366 thousand in 2016 and is expected to reach $28,051 thousand in 2023, an annual growth rate of 4.6% from 2017 to 2023. The BCG vaccine market in India maintains its highest share of the global BCG vaccine market.

The Bacillus Calmette-Gurin (BCG) vaccine is currently the only vaccine available for tuberculosis prevention. BCG vaccine is recommended for healthy babies at birth in countries where tuberculosis is common.

The major factor that contributes to the market growth are increase in incidence rate of tuberculosis in developing nations, rise in R&D activities related to vaccines, and growth in government initiatives and focus on immunization programs globally. However, side reactions of BCG vaccines on patients and shortage of vaccine supply hinder the market growth. Moreover, untapped market opportunities in developing regions are expected to provide numerous opportunities for market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4419

The major companies profiled in the report include
• Merck & Co. Inc.
• Sanofi Pasteur
• Japan BCG Laboratory
• China National Biotec Group (a subsidiary of China National Pharmaceutical Group Corporation)
• Serum Institute of India Pvt. Ltd.
• InterVax Ltd.
• GreenSignal Bio Pharma Limited (GSBPL)
• Statens Serum Institut.

The pediatrics segment is expected to maintain its dominant position during the analysis period, as the vaccine is administered to all the children at the time of birth. As BCG is recommended for only one dose; therefore, it is used rarely in the case of adults.

Flat 20% Discount on All Type of License (https://www.alliedmarketresearch.com/checkout/723404) * Offer Valid Till 20th April 2019

Key Findings of the BCG Vaccine Market:a
• The pediatrics segment accounted for more than three-fourths share of the global market in 2016.
• China is expected to grow at a rapid CAGR of 6.2% from 2017 to 2023.
• India accounted for one-sixth of the global market in 2016.
• The adults segment is expected to grow at a CAGR of 3.6% from 2017 to 2023.

Access Full Summery @ https://www.alliedmarketresearch.com/BCG-vaccine-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release BCG Vaccine Market - Rise in R&D Activities Related To Vaccines, And Growth in Government Initiatives Boost the Market Growth here

News-ID: 1692121 • Views: 299

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for BCG

BCG Vaccine Booming Segments; Investors Seeking Growth | Sanofi Pasteur, Japan B …
Latest Research Study on Global BCG VaccineMarket published by AMA, offers a detailed overview of the factors influencing the global business scope.Global BCG Vaccine Market research report shows the latest market insights with upcoming trends and breakdown of the products and services.The report provides key statistics on the market status, size, share, growth factors, Challenges and Current Scenario Analysis of the Global BCG Vaccine.This Report also covers the emerging player's
BCG Vaccine Market Share, Size, Forecast and Trends by 2023
BCG Vaccine Market Overview BCG vaccine stands for Bacillus Calmette-Gurin (BCG) vaccine. It prevents TB and is the only vaccine in the market which could do that. A single dose is given to an infant soon after birth in countries with high occurrence of TB. In countries which TB is not a common occurrence only high risk infants are treated with it. Adults are only treated with this vaccine if their
Emerging Trends in BCG Vaccine Market by 2023
BCG vaccine market was valued at from $20,366 thousand in 2016, and is estimated to reach $28,051 thousand by 2023, growing at a CAGR of 4.6% from 2017 to 2023. The Indian BCG vaccines market holds the highest share in the global BCG vaccines market. Get PDF sample copy @ https://www.alliedmarketresearch.com/request-sample/4419 As there is no current alternative to BCG vaccine, therefore there is an urgent need to improve the methods used for
Global BCG Vaccine Market 2018- Merck Sanofi Pasteur, Japan BCG Lab, China Natio …
The Global BCG Vaccine Industry 2018 Market Research Report is a professional and in-depth study on the current state of the BCG Vaccine industry. Firstly, BCG Vaccine Market report provides a basic overview of the BCG Vaccine industry including definitions, classifications, applications and BCG Vaccine industry chain structure. Global BCG Vaccine Market analysis is provided for the international market including development history, BCG Vaccine industry competitive landscape analysis, and major regions
BCG Vaccine Industry Worldwide Market Research Report 2018
Description: The Global BCG Vaccine market size was around USD 0.021 million in 2017. It is expected to grow at a CAGR of 4.6% to reach USD 0.03 million by 2022. BCG vaccine stands for Bacillus Calmette-Gurin (BCG) vaccine. It prevents TB and is the only vaccine in the market which could do that. A single dose is given to an infant soon after birth in countries with high occurrence of TB.
Global BCG Vaccine Market 2017 Forecast to 2022
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) BCG Vaccine Market 2017 Forecast to 2022 TOC and List of Figures and Tables https://www.researchbymarkets.com/report/global-north-america-europe-and-asia-pacific-south-america-middle-east-and-africa-bcg-vaccine-market-2017-forecast-to-2022-2227.html BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of